2025. pH-Responsive Mesoporous Silica Nanoparticles Functionalized with Aptamers for Targeted siRNA Delivery in Triple-Negative Breast Cancer Therapy. Nano-Bio Convergence Letters. 1, 1 (Sep. 2025), 16–30.